The Lung Imaging Biomarker Consortium

The Lung Imaging Biomarker Consortium (LIBC) is a collaborative effort that develops and validates advanced lung imaging techniques, primarily using CT scans, to better understand and monitor lung diseases like emphysema and COPD. By standardizing how images are taken and analyzed, LIBC helps researchers identify early signs of lung damage, assess disease progression, and evaluate treatment effectiveness more accurately. This improves diagnosis, supports personalized care, and advances clinical research, ultimately aiming for better outcomes for patients with lung conditions.